Literature DB >> 28322863

Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns.

Bertram Bengsch1, Takuya Ohtani2, Ramin Sedaghat Herati3, Niels Bovenschen4, Kyong-Mi Chang5, E John Wherry6.   

Abstract

The elimination of infected or tumor cells by direct lysis is a key T and NK cell effector function. T and NK cells can kill target cells by coordinated secretion of cytotoxic granules containing one or both pore-forming proteins, perforin and granulysin and combinations of granzyme (Gzm) family effector proteases (in humans: Gzm A, B, K, M and H). Understanding the pattern of expression of cytotoxic molecules and the relationship to different states of T and NK cells may have direct relevance for immune responses in autoimmunity, infectious disease and cancer. Approaches capable of simultaneously evaluating expression of multiple cytotoxic molecules with detailed information on T and NK differentiation state, however, remain limited. Here, we established a high dimensional mass cytometry approach to comprehensively interrogate single cell proteomic expression of cytotoxic programs and lymphocyte differentiation. This assay identified a coordinated expression pattern of cytotoxic molecules linked to CD8 T cell differentiation stages. Coordinated high expression of perforin, granulysin, Gzm A, Gzm B and Gzm M was associated with markers of late effector memory differentiation and expression of chemokine receptor CX3CR1. However, classical gating and dimensionality reduction approaches also identified other discordant patterns of cytotoxic molecule expression in CD8 T cells, including reduced perforin, but high Gzm A, Gzm K and Gzm M expression. When applied to non-CD8 T cells, this assay identified different patterns of cytotoxic molecule co-expression by CD56hi versus CD56dim defined NK cell developmental stages; in CD4 T cells, low expression of cytotoxic molecules was found mainly in TH1 phenotype cells, but not in Tregs or T follicular helper cells (TFH). Thus, this comprehensive, single cell, proteomic assessment of cytotoxic protein co-expression patterns demonstrates specialized cytotoxic programs in T cells and NK cells linked to their differentiation stages. Such comprehensive cytotoxic profiling may identify distinct patterns of cytotoxic potential relevant for specific infections, autoimmunity or tumor settings.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxic; Granzymes and perforin; Mass cytometry; NK cell; T cell; T cell differentiation

Mesh:

Substances:

Year:  2017        PMID: 28322863      PMCID: PMC5605401          DOI: 10.1016/j.jim.2017.03.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

Review 1.  Granzymes regulate proinflammatory cytokine responses.

Authors:  Annette C Wensink; C Erik Hack; Niels Bovenschen
Journal:  J Immunol       Date:  2015-01-15       Impact factor: 5.422

2.  Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential.

Authors:  Juandy Jo; Bertram Bengsch; Bianca Seigel; Sibylle J Rau; Julia Schmidt; Emmanuel Bisse; Peter Aichele; Ulrike Aichele; Lars Joeckel; Cathy Royer; Karine Sá Ferreira; Christoph Borner; Thomas F Baumert; Hubert E Blum; Volker Lohmann; Richard Fischer; Robert Thimme
Journal:  J Hepatol       Date:  2012-03-14       Impact factor: 25.083

3.  Noncytotoxic inhibition of cytomegalovirus replication through NK cell protease granzyme M-mediated cleavage of viral phosphoprotein 71.

Authors:  Robert van Domselaar; Leonne E Philippen; Razi Quadir; Emmanuel J H J Wiertz; J Alain Kummer; Niels Bovenschen
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

4.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.

Authors:  D Kägi; B Ledermann; K Bürki; P Seiler; B Odermatt; K J Olsen; E R Podack; R M Zinkernagel; H Hengartner
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

5.  CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15.

Authors:  Ling Ling Ma; Jason C L Spurrell; Jian Fei Wang; Graham G Neely; Slava Epelman; Alan M Krensky; Christopher H Mody
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

6.  Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.

Authors:  Kai Bratke; Michael Kuepper; Britta Bade; J Christian Virchow; Werner Luttmann
Journal:  Eur J Immunol       Date:  2005-09       Impact factor: 5.532

7.  PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.

Authors:  Delphine Sauce; Jorge R Almeida; Martin Larsen; Laurine Haro; Brigitte Autran; Gordon J Freeman; Victor Appay
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

8.  Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.

Authors:  Dong Zhang; Premlata Shankar; Zhan Xu; Brooke Harnisch; Gang Chen; Christoph Lange; Sandra J Lee; Hernan Valdez; Michael M Lederman; Judy Lieberman
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

9.  HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Authors:  V Appay; D F Nixon; S M Donahoe; G M Gillespie; T Dong; A King; G S Ogg; H M Spiegel; C Conlon; C A Spina; D V Havlir; D D Richman; A Waters; P Easterbrook; A J McMichael; S L Rowland-Jones
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

10.  Continuous Effector CD8(+) T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population.

Authors:  H Hamlet Chu; Shiao-Wei Chan; John Paul Gosling; Nicolas Blanchard; Alexandra Tsitsiklis; Grant Lythe; Nilabh Shastri; Carmen Molina-París; Ellen A Robey
Journal:  Immunity       Date:  2016-07-12       Impact factor: 31.745

View more
  29 in total

1.  CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Authors:  Benoît P Nicolet; Aurélie Guislain; Floris P J van Alphen; Raquel Gomez-Eerland; Ton N M Schumacher; Maartje van den Biggelaar; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

2.  Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection.

Authors:  Nina Hensel; Zuguang Gu; Dominik Wieland; Katharina Jechow; Janine Kemming; Sian Llewellyn-Lacey; Emma Gostick; Oezlem Sogukpinar; Florian Emmerich; David A Price; Bertram Bengsch; Tobias Boettler; Christoph Neumann-Haefelin; Roland Eils; Christian Conrad; Ralf Bartenschlager; Dominic Grün; Naveed Ishaque; Robert Thimme; Maike Hofmann
Journal:  Nat Immunol       Date:  2021-01-04       Impact factor: 25.606

3.  Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human.

Authors:  Juanjuan Zhao; Shuye Zhang; Yang Liu; Xiaomeng He; Mengmeng Qu; Gang Xu; Hongbo Wang; Man Huang; Jing Pan; Zhenwen Liu; Zhiwei Li; Lei Liu; Zheng Zhang
Journal:  Cell Discov       Date:  2020-04-28       Impact factor: 10.849

Review 4.  All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity.

Authors:  Ariel Ramírez-Labrada; Cecilia Pesini; Llipsy Santiago; Sandra Hidalgo; Adanays Calvo-Pérez; Carmen Oñate; Alejandro Andrés-Tovar; Marcela Garzón-Tituaña; Iratxe Uranga-Murillo; Maykel A Arias; Eva M Galvez; Julián Pardo
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

5.  Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells.

Authors:  Bertram Bengsch; Takuya Ohtani; Omar Khan; Manu Setty; Sasikanth Manne; Shaun O'Brien; Pier Federico Gherardini; Ramin Sedaghat Herati; Alexander C Huang; Kyong-Mi Chang; Evan W Newell; Niels Bovenschen; Dana Pe'er; Steven M Albelda; E John Wherry
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

6.  Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis.

Authors:  Tyler J Alban; Alvaro G Alvarado; Mia D Sorensen; Defne Bayik; Josephine Volovetz; Emily Serbinowski; Erin E Mulkearns-Hubert; Maksim Sinyuk; James S Hale; Giovana R Onzi; Mary McGraw; Pengjing Huang; Matthew M Grabowski; Connor A Wathen; Manmeet S Ahluwalia; Tomas Radivoyevitch; Harley I Kornblum; Bjarne W Kristensen; Michael A Vogelbaum; Justin D Lathia
Journal:  JCI Insight       Date:  2018-11-02

7.  Protocol for Creating Antibodies with Complex Fluorescence Spectra.

Authors:  Madeline E McCarthy; Caitlin M Anglin; Heather A Peer; Sevanna A Boleman; Stephanie R Klaubert; Marc R Birtwistle
Journal:  Bioconjug Chem       Date:  2021-05-19       Impact factor: 4.774

Review 8.  Unraveling exhaustion in adaptive and conventional NK cells.

Authors:  Aimee M Merino; Hansol Kim; Jeffrey S Miller; Frank Cichocki
Journal:  J Leukoc Biol       Date:  2020-07-29       Impact factor: 4.962

9.  Tissue Determinants of Human NK Cell Development, Function, and Residence.

Authors:  Pranay Dogra; Chiara Rancan; Wenji Ma; Marta Toth; Takashi Senda; Dustin J Carpenter; Masaru Kubota; Rei Matsumoto; Puspa Thapa; Peter A Szabo; Maya Meimei Li Poon; Jacky Li; Janice Arakawa-Hoyt; Yufeng Shen; Lawrence Fong; Lewis L Lanier; Donna L Farber
Journal:  Cell       Date:  2020-02-13       Impact factor: 41.582

Review 10.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.